Exclusivity and Confidentiality AgreementExclusivity and Confidentiality Agreement • December 22nd, 2010 • Wonder Holdings, Inc. • Pharmaceutical preparations • Delaware
In connection with your consideration of a possible transaction involving Matrixx Initiatives, Inc. (the “Company”), the Company is prepared to make available to you certain information concerning its business, financial condition, operations, assets, and liabilities. As a condition to such information being furnished to you and your directors, officers, employees, Primus Therapeutics, Inc., agents, or advisors (including, without limitation, your attorneys, accountants, consultants, bankers, and financial advisors) (collectively the “Representatives”), you agree to treat any information concerning the Company (whether prepared by you, your Representatives, or otherwise and irrespective of the form of communication) that has been or will be furnished to you or your Representatives by or on behalf of the Company (herein collectively referred to as the “Evaluation Material”) in accordance with the provisions of this letter agreement, and to take or abstain from taking certain other actio
